Olaf Elixmann

B.Braun Avitum AG engages in the development, production, and distribution of medical and pharmaceutical products used in dialysis, plasmapheresis, and other blood treatments. It also operates dialysis stations, and provides medical and consulting services. The company was founded on October 5, 2000 and is headquartered in Melsungen, Germany.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.